MoonLake Immunotherapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $19 | $19 |
Gross Profit | -28 | -22 | 16 | |
EBITDA | -43,079 | -30,550 | -19,797 | -15,025 |
EBIT | -43,112 | -30,578 | -19,820 | -15,028 |
Net Income | -35,390 | -24,267 | -13,673 | -7,437 |
Net Change In Cash | 0 | 0 | 19 | 19 |
Free Cash Flow | -25,407 | -27,890 | -15,160 | -12,628 |
Cash | 375,656 | 342,791 | 458,441 | 451,169 |
Basic Shares | 62,896 | 62,874 | 62,637 | 59,914 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 |
|---|---|---|
Revenue | $0 | $0 |
Gross Profit | -13 | -12 |
EBITDA | -54,109 | -65,049 |
EBIT | -54,123 | -65,061 |
Net Income | -36,007 | -64,506 |
Net Change In Cash | 0 | 0 |
Cost of Revenue | 31,458 | |
Free Cash Flow | -43,062 | -55,909 |
Cash | 451,169 | 39,505 |
Basic Shares | 49,122 | 29,361 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.56 |
2024-06-30 | -$0.39 |
2024-03-31 | -$0.22 |
2023-12-31 | -$0.12 |
